三诺生物
(300298)
| 流通市值：100.17亿 | | | 总市值：124.14亿 |
| 流通股本：4.55亿 | | | 总股本：5.64亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 979,713,629.33 | 844,696,443.76 | 795,422,346.7 | 675,706,026.01 |
| 应收票据及应收账款 | 529,523,986.29 | 620,256,105.14 | 527,201,805.17 | 614,092,644.67 |
| 应收账款 | 529,523,986.29 | 620,256,105.14 | 527,201,805.17 | 614,092,644.67 |
| 应收款项融资 | 14,520,569.96 | 30,993,722.23 | 12,988,045.94 | 8,630,966.48 |
| 预付款项 | 59,435,743.92 | 47,128,273.25 | 60,873,362.4 | 47,616,870.69 |
| 其他应收款合计 | 18,882,863.76 | 10,840,127.86 | 39,548,497.06 | 44,245,018.93 |
| 存货 | 659,373,378.5 | 662,843,666.87 | 681,094,723.03 | 670,143,819.66 |
| 一年内到期的非流动资产 | 369,027.71 | 400,274.26 | - | - |
| 其他流动资产 | 63,882,137.99 | 54,720,662.21 | 43,927,439.07 | 42,409,875.27 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,325,701,337.46 | 2,381,879,275.58 | 2,211,056,219.37 | 2,102,845,221.71 |
| 非流动资产: | | | | |
| 长期应收款 | 286,906.97 | 345,569.37 | 834,832.57 | 922,910.9 |
| 长期股权投资 | 14,278,460.09 | 14,875,560.06 | 46,983,808.98 | 47,878,467.03 |
| 其他权益工具投资 | 261,085,609.28 | 298,718,825.99 | 298,455,130.32 | 310,885,012 |
| 固定资产 | 1,599,601,452.73 | 1,622,513,646.62 | 1,643,902,735.86 | 1,655,458,350.95 |
| 在建工程 | 240,846,014.95 | 210,876,362.92 | 180,160,186.03 | 173,369,491.96 |
| 使用权资产 | 18,129,504.38 | 22,015,303.18 | 21,452,895.78 | 25,568,232.03 |
| 无形资产 | 254,823,549.74 | 264,465,770.3 | 264,541,000.62 | 273,337,307.09 |
| 商誉 | 1,129,779,585.67 | 1,130,805,300.22 | 1,112,603,894.97 | 1,124,610,788.83 |
| 长期待摊费用 | 14,127,298.16 | 15,419,618.32 | 16,232,588.24 | 17,839,934.01 |
| 递延所得税资产 | 107,029,994.34 | 110,574,156.43 | 107,187,053.47 | 103,634,578.25 |
| 其他非流动资产 | 27,962,865.11 | 25,075,563.39 | 30,028,718.66 | 39,987,719.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,667,951,241.42 | 3,715,685,676.8 | 3,722,382,845.5 | 3,773,492,792.07 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,993,652,578.88 | 6,097,564,952.38 | 5,933,439,064.87 | 5,876,338,013.78 |
| 流动负债: | | | | |
| 短期借款 | 25,027,141.13 | 130,076,388.25 | 69,544,556.74 | 73,763.38 |
| 应付票据及应付账款 | 343,806,543.35 | 345,823,698.54 | 265,252,396.61 | 306,185,293.51 |
| 其中：应付票据 | 18,290,000 | 3,920,000 | 4,449,034.32 | 7,998,117.66 |
| 应付账款 | 325,516,543.35 | 341,903,698.54 | 260,803,362.29 | 298,187,175.85 |
| 合同负债 | 460,120,354.56 | 446,358,451.33 | 433,792,257.94 | 461,147,281.08 |
| 应付职工薪酬 | 177,204,937.71 | 210,547,550.32 | 196,386,597.41 | 172,420,752.69 |
| 应交税费 | 38,162,501.01 | 50,347,844.12 | 46,101,787.41 | 42,360,633.24 |
| 其他应付款合计 | 132,365,599.05 | 140,105,564.01 | 134,630,810.18 | 110,999,980.76 |
| 其中:应付利息 | - | - | -30,050 | - |
| 一年内到期的非流动负债 | 117,563,828.5 | 233,874,703.61 | 390,762,317.97 | 393,058,913.5 |
| 其他流动负债 | 142,253,796.94 | 136,576,527.18 | 24,618,877.47 | 25,186,539.69 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,436,504,702.25 | 1,693,710,727.36 | 1,561,089,601.73 | 1,511,433,157.85 |
| 非流动负债: | | | | |
| 长期借款 | 72,120,000 | 120,000 | 65,312,625 | 98,212,625 |
| 应付债券 | 463,574,259.35 | 456,036,319.65 | 456,190,744.12 | 448,868,832.59 |
| 租赁负债 | 8,886,325.27 | 11,102,029.64 | 17,396,824.62 | 20,000,324.28 |
| 长期应付职工薪酬 | 1,573,756.03 | 1,588,539.79 | 1,353,153.82 | 1,353,580.94 |
| 预计负债 | - | - | 95,416,327.02 | 97,827,423.66 |
| 递延收益 | 129,943,971.19 | 132,467,466.2 | 117,864,805.89 | 120,185,270.54 |
| 递延所得税负债 | 30,989,158.73 | 32,923,687.22 | 43,612,300.23 | 38,955,807.76 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 707,087,470.57 | 634,238,042.5 | 797,146,780.7 | 825,403,864.77 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,143,592,172.82 | 2,327,948,769.86 | 2,358,236,382.43 | 2,336,837,022.62 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 564,265,375 | 564,265,375 | 564,265,375 | 564,265,375 |
| 其他权益工具 | 123,953,405.74 | 123,953,405.74 | 123,953,405.74 | 123,953,405.74 |
| 资本公积 | 1,107,114,047.71 | 1,104,915,880.07 | 1,094,754,850.02 | 1,090,307,434.07 |
| 减:库存股 | 181,302,394.3 | 181,302,394.3 | 253,582,392.93 | 253,582,392.93 |
| 其他综合收益 | 107,478,519.9 | 136,397,201.91 | 108,851,770.12 | 136,594,643.18 |
| 盈余公积 | 486,618,446.69 | 482,490,060.31 | 437,766,994.19 | 437,305,484.27 |
| 未分配利润 | 1,222,529,613.05 | 1,127,020,330.07 | 1,100,794,523.6 | 1,043,399,315.01 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,430,657,013.79 | 3,357,739,858.8 | 3,176,804,525.74 | 3,142,243,264.34 |
| 少数股东权益 | 419,403,392.27 | 411,876,323.72 | 398,398,156.7 | 397,257,726.82 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,850,060,406.06 | 3,769,616,182.52 | 3,575,202,682.44 | 3,539,500,991.16 |
| 负债和股东权益合计 | 5,993,652,578.88 | 6,097,564,952.38 | 5,933,439,064.87 | 5,876,338,013.78 |
| 公告日期 | 2025-04-29 | 2025-04-21 | 2024-10-24 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |